Melmed S, Colao A, Barkan A, et al. Guidelines for Acromegaly Management: An Update. J Clin Endocrinol Metab, 2009, 94: 1509-1517.
Colao A, Ferone D, Marzullo P, et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev, 2004, 25:102-152.
Clayton RN. Cardiovascular function in acromegaly. Endocr Rev, 2003, 24:272-277.
Biermasz NR, Dekker FW, Pereira AM. et al. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J Clin Endocrinol Metab, 2004, 89:3306-3312.
Holdaway IM, Rajasoorya CR, Gamble GD, et al. Long-term treatment outcome in acromegaly. Growth Horm IGF Res, 2003, 13:185-192.
Holdaway IM, Raja C. Rajasoorya CR, et al. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab, 2004, 89:667-674.
Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol, 2008, 159:89-95.
Kauppinen-Makelin R, Sane T, Reunanen A, et al. A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab, 2005, 90:4081-4086.
毛志钢, 王海军, 何东升, 等. 影响垂体生长激素腺瘤经蝶手术疗效的因素分析. 中国微侵袭神经外科杂志, 2006, 11: 151-153.
王海军,毛志钢,朱永红, 等. 激素评估垂体生长激素腺瘤经蝶手术疗效. 中华神经医学杂志, 2006, 5:45-48.
Zirkzee EJ, Corssmit EP, Biermasz NR, et al. Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery. J Clin Endocrinol Metab, 2004, 89(9): 4320–4324.
|